Effect of Somatosensory Motor Control With and Without Kinesio Tape in Patients With Sciatica

August 10, 2026 updated by: Riphah International University

Effects of Somatosensory Motor Control With and Without Kinesio Tape on Pain, Range of Motion of Lumbar, Dynamic Balance and Function Disability in Patients With Sciatica

Sciatica can be defined as a radicular pain that runs through the sciatic nerve from the lower back to the lower limbs and also may be associated with weakness or numbness in the muscles. These symptoms may affect proprioception, dynamic balance and functional mobility, which result in limitations of activity and disability. Training to improve somatosensory motor control has been shown to be effective in improving coordination and postural stability and Kinesio taping has the potential to increase proprioceptive input, decrease pain and aid functional recovery.

Study Overview

Detailed Description

To evaluate the additional effects of kinesio taping when added to somatosensory motor control training on pain, active range of motion of the lumbar spine, proprioceptive related postural control, dynamic balance and functional disability in people with discogenic sciatica.

The study was an accessor-blinded randomized controlled trial approved by the ethical council of Riphah College of Rehabilitation & Allied Health Sciences and was carried out for 11 months in 4 hospitals at Sialkot. 58 Participants were randomized; among which 54 participants completed the intervention and were included in per-protocol analysis with 27 participants in each group. During the 6-week intervention period, Group A was administered with somatosensory motor control training, conventional therapy, and Kinesio taping; while Group B was administered with the same intervention with the exception of Kinesio taping. The following outcome measures were used: Visual Analog Scale, Oswestry Disability Index, Modified Schober Test, Y-Balance Test, Romberg Test, and Tandem Stand Test. Data was analyzed in SPSS version 25 with statistical significance being considered as p<0.05.

Study Type

Interventional

Enrollment (Estimated)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Sialkot, Pakistan
        • Recruiting
        • Civil hospital Sialkot
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Both male and females.

    • Age between 35-50 years.
    • Discogenic pain due to Diagnosed herniation lumbar disc L4/L5 and L5/S1 (confirmed by MRI).
    • unilateral leg pain radiating below the knee accompanied by numbness, tingling, or weakness in the affected leg.
    • Pain persists between 3-6 months.
    • Positive Straight Leg Raise (SLR) test between 40° to 70°, suggestive of neural irritation.

Exclusion Criteria:

  • • Patients with inflammatory diseases like ankylosing spondylitis, vertebral collapse, rheumatoid arthritis, stenosis, spondylolisthesis, or osteoporosis.

    • Recent spinal surgery
    • Abdominal or lower limb surgery
    • Pregnancy
    • Skin allergies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A

somatosensory motor control (include PNF, somatosensory exercises and vestibular exercises) + Kinesiology taping+ conventional Treatment Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks

Assessment Points:

Pre-treatment (Baseline) Post-treatment (End of 6th week)

Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks

Assessment Points:

Pre-treatment (Baseline) Post-treatment (End of 6th week)

Active Comparator: Group B

somatosensory motor control (include PNF, somatosensory exercises and vestibular exercises) + conventional Treatment Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks

Assessment Points:

Pre-treatment (Baseline) Post-treatment (End of 6th week)

Total Time per Session: 45-60 minutes Frequency: 3 sessions per week Total Duration: 6 weeks

Assessment Points:

Pre-treatment (Baseline) Post-treatment (End of 6th week)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale
Time Frame: Baseline and post 6 weeks
The Visual Analogue Scale (VAS) is scored by measuring the distance in millimeters (from 0 to 100 mm) or centimeters (0 to 10 cm) on a straight line between the "no pain" anchor and the patient's mark. Higher numbers mean more intense symptoms.
Baseline and post 6 weeks
lumbar range of motion
Time Frame: Baseline and post 6 weeks
Modified Schober Test, The Schober Test evaluates lower back movement. Scoring is based on how much the distance between marked points on the spine increases during forward bending. A starting 15 cm span should stretch to 20 cm or more; an increase under 5 cm shows reduced flexibility
Baseline and post 6 weeks
dynamic balance
Time Frame: Baseline and post 6 weeks
Y balance test, The Y Balance Test is a standardized three-direction reach test (anterior, posteromedial, posterolateral) used to assess dynamic balance, limb asymmetry, and injury risk, with anterior reach asymmetry >4 cm and composite scores below ~89-94% linked to higher injury risk.
Baseline and post 6 weeks
functional disability
Time Frame: Baseline and post 6 weeks
Oswestry Disability Index (ODI), The Oswestry Disability Index (ODI) is a 10-item patient questionnaire scored from 0 to 5 per question. Total the points, divide by the maximum possible score (usually 50, or 5 × questions answered), and multiply by 100 to get a percentage score from 0% to 100%. You can calculate scores interactively using tools like OrthoToolKit.
Baseline and post 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aiza Yousaf, MSOMPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

July 21, 2026

First Submitted That Met QC Criteria

August 10, 2026

First Posted (Actual)

August 11, 2026

Study Record Updates

Last Update Posted (Actual)

August 11, 2026

Last Update Submitted That Met QC Criteria

August 10, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe